Despite the growing global discourse around the revenue potential of waste to wealth — i.e., reimagining waste as a valuable...
By KIM BELLARD The most (unintentionally) amusing story I read this week was Tim Higgin’s Wall Street Journal article Alex...
Subscribe to Our Weekly Newsletter, “NextBillion Notes” Published each Wednesday, our e-newsletter features NextBillion’s latest original articles, along with a...
By JOHN SAMARAS Ask what Ozempic costs. The honest answer runs from $25 a month to $1,100 a month, and...
By CRAIG HAUBEN Ask anyone outside healthcare who resists clinical AI and you’ll get a confident answer. The older doctors....
By DAMIAN WONJO Every clinician keeps a private list of the patients they don’t see. Not the ones who cancel,...
The European Union Deforestation Regulation (EUDR) represents one of the most ambitious and well-meaning legislative efforts to protect our planet’s...
By MATTHEW HOLT It’s hard to imagine but I may now be in possession of the stupidest letter I’ve ever...
Few developments have been as striking in the impact investing space as the rise of gender-lens investing (GLI) since the...
By JEFF GOLDSMITH In his wonderful and pragmatic new book, A Giant Leap, Dr. Robert Wachter cautions his professional colleagues that...
